Dava al-Balgham: One of the Traditional Iranian Medicine Products
Abstract
Background and Aim: Nowadays, overweight and obesity are considered as major risk factors for common disorders such as metabolic syndrome, non-alcoholic fatty liver diseases, type 2 diabetes, and cardio cerebral vascular disease. Medical advice for preventing these diseases includes measures such as weight loss with diet and exercise, blood sugar and lipids control, the rise of fiber, and finally antioxidants and vitamin E consumption. Iranian traditional medicine (ITM) is a holistic medicine that introduces several remedies for the prevention and treatment of diseases through nutrition and lifestyle modifications, and administration of herbal medicines. This study examines new articles on the uses of Dava al-Balgham tablets, one of the traditional Iranian medicine products in ITM texts. Materials and Methods: Initially, the use of the combination drug, Dava al-Balgham, and its constituent herbs (Nigella sativa, Zataria multiflora, Pistacia lentiscus, and Trachyspermum ammi) in ITM sources were searched, and then new articles in the new medicinal and pharmacology studies and databases such as PubMed, Google Scholar, and SID about this combined drug and its constituent herbs, were ccollected and reviewed. Results: Studies that have been carried out on this combined drug, have documented effects such as a reducing body mass index and abdominal circumference, reducing cholesterol and triglyceride levels, and reducing serum liver enzymes. Moreover, for herbs that make up this combination, effects such as antioxidant, hepatoprotective, lowering hepatic enzyme and lipid and glucose levels, improving digestive tract disorders such as bloating and dyspepsia have been reported. Conclusion: According to the studies conducted on the combination drug Dava al-Balgham and its constituent herbs, the effects of this drug could prevent and treat diseases such as overweight, increased blood lipids, non-alcoholic fatty liver diseases and digestive problems, including dyspepsia and bloating.References
Pozza C, Isidori AM. What’s Behind the Obesity Epidemic? In Imaging in Bariatric Surgery. 2018 (pp. 1-8). Springer, Cham.
Balhareth A, Meertens R, Kremers S, Sleddens E. Overweight and obesity among adults in the G ulf S tates: A systematic literature review of correlates of weight, weight‐related behaviours, and interventions. Obesity Reviews. 2019 Jan 17.
de Onis M, Onyango AW, Borghi E, et al. Comparison of the World Health Organization (WHO) child growth standards and the National Center for Health Statistics/WHO international growth reference: implications for child health programmes. Public Health Nutr. 2006; 9:942.
Yu N, Ruan Y, Gao X, Sun J. Systematic Review and Meta-Analysis of Randomized, Controlled Trials on the Effect of Exercise on Serum Leptin and Adiponectin in Overweight and Obese Individuals. Horm Metab Res. 2017;49(03):164-73.
Bessesen DH, Van Gaal LF. Progress and challenges in anti-obesity pharmacotherapy. The Lancet Diabetes & Endocrinology. 2018;6(3):237-48.
Hasani-Ranjbar S, Jouyandeh Z, Abdollahi M. A systematic review of anti-obesity medicinal plants-an update. Journal of Diabetes & Metabolic Disorders. 2013;12(1):28.
WHO W. WHO traditional medicine strategy 2014–2023. World Health Organization. 2013.
Gorji Z, Choopani R, Ghamarchehreh ME, Hekmatdoost A, Dehghan S. the recommended iranian traditional medicine (persian medicine) diet in non-alcoholic fatty liver disease. Indo American journal of pharmaceutical sciences. 2017;4(12):4551-62.
Nazem Jahan MA. Exir-e-a-Aezam. . 2 ed. Tehran: Tehran University of Medical Sciences.; 1387.
Hamidnia L, Nematy M, Salari R, Taghipour A, Motavasselian M. Comparing the efficacy of therapeutic packages in Persian Medicine with Classical Medicine in overweight patients: a randomized clinical trial. Electronic physician. 2018;10(6):6892.
Ibn Sina AA. al-Qanun fi al-tibb. Alamy Le-Al-Matbooat institute, Lebanon. 2005;3:125-7.
Aghili Alawi Shirazi SMHiMH. Qrabadyn Kabir. First ed. Tehran: Tehran University of Medical Sciences and Health Services Institute of Medical History Studies, Islamic and Complementary Medicine.
Khorasani A, Hussain SM. Kholase al-hekmat. Correction by professor Nazim. Tehran. First print. 2005; 1.
Aghili Alawi Shirazi SMHiMH. Makhzan Al-adviyeh (new edition). 2. ed. Tehran. University of Medical Sciences. 1390.
M Zarshenas M, Ranjbar Farrokhi R, Akhavein M, Reza Kiafar M. A panoramic view of chronic liver diseases and natural remedies reported in Traditional Persian Medicine. Current pharmaceutical design. 2016;22(3):350-64.
Moradi, Hossein. “Effect of an Iranian traditional medicine product on the serum level of liver enzymes in patients with non-alcoholic fatty liver disease: A randomized clinical trial”. Faculty of Traditional Iranian Medicine, Qom University of medical science; 1397.
Empties, Majid. “Evaluation of the effect of treatment of traditional medicine in Iran on the serum lipids level in patients with hyperlipidemia “. Faculty of Traditional Iranian Medicine, Tehran University of medical science, 1390.
Ahmad A, Husain A, Mujeeb M, Khan SA, Najmi AK, Siddique NA, et al. A review on therapeutic potential of Nigella sativa: A miracle herb. Asian Pacific journal of tropical biomedicine. 2013;3(5):337-52.
Kaatabi H, Bamosa AO, Badar A, Al-Elq A, Abou-Hozaifa B, Lebda F, et al. Nigella sativa improves glycemic control and ameliorates oxidative stress in patients with type 2 diabetes mellitus: placebo controlled participant blinded clinical trial. PloS one. 2015;10(2):e0113486.
Mahdavi R, Namazi N, Alizadeh M, Farajnia S. Nigella sativa oil with a calorie-restricted diet can improve biomarkers of systemic inflammation in obese women: A randomized double-blind, placebo-controlled clinical trial. Journal of clinical lipidology. 2016;10(5):1203-11.
Al‐Okbi SY, Mohamed DA, Hamed TE, Edris AE. Potential protective effect of Nigella sativa crude oils towards fatty liver in rats. European Journal of Lipid Science and Technology. 2013;115(7):774-82.
Badar A, Kaatabi H, Bamosa A, Al-Elq A, Abou-Hozaifa B, Lebda F, et al. Effect of Nigella sativa supplementation over a one-year period on lipid levels, blood pressure and heart rate in type-2 diabetic patients receiving oral hypoglycemic agents: nonrandomized clinical trial. Annals of Saudi medicine. 2017;37(1):56.
Ibrahim RM, Hamdan NS, Mahmud R, Imam MU, Saini SM, Rashid SN, et al. A randomised controlled trial on hypolipidemic effects of Nigella Sativa seeds powder in menopausal women. Journal of translational medicine. 2014;12(1):82.
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation. Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. This work is licensed under a Creative Commons license (CC-BY). However, the license permits any user to read, copy, redistribute and and make derivative the material in any medium or format for any purpose, even commercially.
